Innate Pharma S.A Profit Margin 2019-2021 | IPHA
Current and historical gross margin, operating margin and net profit margin for Innate Pharma S.A (IPHA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Innate Pharma S.A net profit margin as of June 30, 2021 is 0%.
|Innate Pharma S.A Annual Profit Margins
|Innate Pharma S.A Quarterly Profit Margins
||Medical - Biomedical and Genetics
Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.